Researchers have developed a urine test for a three-gene signature that can indicate risk of kidney transplant rejection. The test could identify the risk of rejection weeks or months before symptoms appear. "We have, for the first time, the opportunity to manage transplant patients in a more precise, individualized fashion. This is good news since it moves us from the current one-size-fits-all treatment model to a much more personalized plan," said lead author Dr. Manikkam Suthanthiran from Weill Cornell Medical College. The findings were reported in the New England Journal of Medicine.
Published in Brief: